• Tuberculosis and Respiratory Diseases
• /
• 제59권4호
• /
• pp.427-431
• /
• 2005

저자들은 점점 진행하는 하지무력증을 주소로 내원한 48세 남자에서 전기생리검사를 시행하여 VGCC 양성인 LEMS를 진단하였고, 동반한 소세포폐암을 진단하여 항암요법을 시행하였고 완치 판정을 받은 후 특별한 치료 없이도 LEMS의 임상증상과 전기생리검사에서 호전을 보인 1예를 경험하였기에 이를 보고하는 바이다.

• 대한한의학방제학회지
• /
• 제29권4호
• /
• pp.321-329
• /
• 2021

This case study reports the effects of complex Korean medicine treatment, including Nangan-jeon, on Lambert-Eaton myasthenic syndrome (LEMS) accompanied by chronic constipation and abdominal pain as the main symptoms. A 39-year-old woman diagnosed with LEMS with major symptoms, including chronic constipation and acute abdominal pain, received Western treatment. The treatment efficacy was weak and symptoms recurred, so the patient received outpatient treatment and 13 days of hospitalization for active Korean medicine treatment, including Nangan-jeon. During outpatient treatment and hospitalization, defecation frequency and the numeric rating scale (NRS) for abdominal pain and abdominal cold feeling were measured. The NRS for abdominal pain and cold decreased from 8 at admission to 3 and 0, respectively, at discharge. Defecation frequency increased significantly from once or twice a month to once every 2-3 days during hospitalization. This study results that complex Korean medicine treatment, including Nangan-jeon may be useful for treating patients who mainly complain of autonomic neurological symptoms, among patients diagnosed with LEMS. In addition, it is believed that it could be basic data applicable to more LEMS patient treatment cases.

• Tuberculosis and Respiratory Diseases
• /
• 제45권3호
• /
• pp.596-603
• /
• 1998

소세포 폐암에 동반된 LEMS는 부종양성 증후군의 일종으로 LEMS가 진단된 환자의 50% 이상에서 소세포 폐암이 동반되는데 특히 흡연력이 있는 고령에서 잠재성암을 진단하기 위한 적극적인 노력이 필요하다. 저자 등은 기괸지경 검사상 조직학적으로 진단되지 않았으나 폐암이 강력히 의심되어 적극적으로 수술적 치료를 시행하여 소세포 폐암을 진단하였고, 수술 후 LEMS의 임상양상이 호전되었으며 항암 화학요법후 추가로 호전된 증례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

• Annals of Clinical Neurophysiology
• /
• 제8권1호
• /
• pp.6-15
• /
• 2006

Intravenous immunoglobulin (IVIg) is the treatment of choice for many autoimmune neuropathic disorders such as Guillain-Barre syndrome (GBS), chronic inflammatory Demyelinating neuropathy (CIDP), and multifocal motor neuropathy (MMN). IVIg is preferred because the adverse reactions are milder and fewer than the other immune-modulating methods such as steroid, other immunosuppressant such as azathioprine, and plasmapheresis. IVIg also has been used in other autoimmune neuromuscular disorders (inflammatory myopathy, myasthenia gravis, and Lambert-Eaton myasthenic syndrome) and has been known as safe and efficient agent in these disorders. Since IVIg would get more indications and be used more commonly, clinicians need to know the detailed mechanism of action, side effects, and practical points of IVIg.